using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment
Published 1 year ago • 65 plays • Length 1:41Download video MP4
Download video MP3
Similar videos
-
1:32
the importance of cytogenetics and molecular profiling for accurate aml/mds diagnosis
-
1:57
combining molecular and clinical data to predict survival & transformation risk in patients with mds
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
3:01
challenges in distinguishing between pre-mds states and mds, and approaches to improve diagnosis
-
4:25
the challenges with accurately diagnosing and risk-stratifying patients with mds
-
4:31
labmt: impact of treatment prior to allogenic hct in mds
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
1:40
utilizing ai for individualized treatment-adjusted risk stratification in newly diagnosed myeloma
-
1:12
using biomarkers and genomics to inform treatment strategy in all
-
2:39
shallow wgs vs conventional cytogenetic analysis for diagnosing and stratifying mds
-
3:36
the genetic landscape of mds: how this is improving & impacting the development of therapies
-
2:04
state-of-the-art treatment for hr-mds
-
3:22
performance of the aipss-mds ml model in predicting os & leukemic transformation in cmml
-
1:17
phase ii study of tosedostat in mds
-
1:06
the current state of the art in hr-mds and the need to improve treatment approaches
-
3:16
developing patient-specific mrd markers for predicting and preventing mds relapse post-sct
-
4:01
the latest genomic updates in the field of mds